role of thrombin generation assays in the diagnosis of acute myocarditis and non-st myocardial infarction

Myocarditis and myocardial infarction share a common clinical characteristics despite significant differences in etiology and pathogenesis. current guidelines recommend using cardiac magnetic resonance imaging (mri) or endocardial biopsy for a definite diagnosis; however, these guidelines are not fully implemented due to the high cost and low availability. we used a thrombin generation assay and simple blood test to characterize both diseases. we conducted a cross-sectional study from to 2018. patients with initial clinical suspicions of non-st elevation myocardial infarction (nstemi) or myocarditis were eligible. all patients were recruited prior to anticoagulant treatment. patients in both groups underwent acceptable standard clinical evaluation. twenty-eight patients were enrolled; 12 patients in the nstemi group and 16 in the myocarditis group. patients in the nstemi group were significantly older than those in the myocarditis group (64.25 ± 9.67 vs. 37.94 ± 19.66 years, p < 0.01, respectively) with a higher prevalence of hyperlipidemia, diabetes mellitus, and ischemic heart disease (p < 0.01 for all). there was no difference between the groups regarding inr, pt, aptt, and serum levels of creatinine, urea, cpk, troponin, and fibrinogen. endogenous thrombin potential (etp), which represents the total thrombin concentration in the plasma, was significantly higher in the myocarditis group than in the nstemi group (2091.88 ± 336.41 vs. 1860.75 ± 438.02 nm × min, p < 0.03). myocarditis and myocardial infarction have a different pattern of thrombin generation thrombogram. the myocarditis group had significantly higher plasma etp than the nstemi group. this finding requires further evaluation to define a numerical threshold, thus avoiding invasive or expensive assessment of myocarditis.